Total and free IgE in evolution of severe asthma after omalizumab treatment

被引：0
|
作者：
Vennera, Maria del Carmen
Pascal, Mariona
Nunez, Ebymar Arismendi
Picado, Cesar
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Asthma; -; management; Treatments; Allergy;
D O I：
10.1183/13993003.congress-2016.PA4117
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4117
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
    Havlucu, Yavuz
    Yorgancioglu, Arzu
    Kurhan, Fikret
    Goktalay, Tugba
    Coskun, Aysin Sakar
    Celik, Pinar
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Asthma exacerbations after discontinuation of omalizumab treatment
    Budny, Wojciech
    Skiepko, Roman
    Lukaszyk, Mateusz
    Klimek, Maciej
    Ki, Ziemowit Zietkows
    Bodzenta-Lukaszyk, Anna
    ALERGIA ASTMA IMMUNOLOGIA, 2015, 20 (04): : 253 - 256
  • [43] Asthma exacerbations after omalizumab treatment discontinuation
    Budny, W.
    Skiepko, R.
    Lukaszyk, M.
    Zietkowski, Z.
    Bodzenta-Lukaszyk, A.
    ALLERGY, 2015, 70 : 554 - 554
  • [44] Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
    D'Amato, Gennaro
    Stanziola, Anna
    Sanduzzi, Alessandro
    Liccardi, Gennaro
    Salzillo, Antonello
    Vitale, Carolina
    Molino, Antonio
    Vatrella, Alessandro
    D'Amato, Maria
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2014, 9
  • [45] Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
    Pelaia, Girolamo
    Vatrella, Alessandro
    Busceti, Maria Teresa
    Gallelli, Luca
    Terracciano, Rosa
    Maselli, Rosario
    CURRENT DRUG TARGETS, 2015, 16 (02) : 171 - 178
  • [46] Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients
    Siergiejko, Zenon
    Swiebocka, Ewa
    Smith, Nicola
    Peckitt, Clare
    Leo, Jo
    Peachey, Guy
    Maykut, Robert
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2223 - 2228
  • [47] Severe asthma and the omalizumab option
    Miller C.W.T.
    Krishnaswamy N.
    Johnston C.
    Krishnaswamy G.
    Clinical and Molecular Allergy, 6 (1)
  • [48] Omalizumab (an Anti-IgE Antibody) in the Treatment of Severe Atopic Eczema
    Ramirez Del Pozo, M. E.
    Contreras Contreras, E.
    Lopez Tiro, J.
    Gomez Vera, J.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2011, 21 (05) : 416 - 417
  • [49] Anti-IgE (Omalizumab) in the treatment of uncontrolled severe asthmatic patients
    Hinojosa, M.
    Huertas, B.
    Gonzalez-Cervera, J.
    Diez-Gomez, M.
    Sanchez-Cano, M.
    Pacheco, A.
    ALLERGY, 2007, 62 : 209 - 209
  • [50] Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
    Szefler, Stanley
    Antonova, Jenya
    Trzaskoma, Benjamin
    Ortiz, Benjamin
    Paknis, Brandee
    Iqbal, Ahmar
    Goldstein, Stanley
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345